Indegene · NSE: INDGN · BSE: 544172
Q3 FY26 results · Oct–Dec 2025
Indegene reported revenue from operations of ₹942.10 crore (up 30.8% from Q3 FY25) and net profit of ₹102.90 crore (down 6.2% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 942.10 | 720.40 | +30.8% | 804.20 | +17.1% |
| Other income | 19.40 | 37.70 | −48.5% | 19.70 | −1.5% |
| Total income | 961.50 | 758.10 | +26.8% | 823.90 | +16.7% |
| Profit before tax | 134.70 | 146.30 | −7.9% | 133.10 | +1.2% |
| Net profit for the period | 102.90 | 109.70 | −6.2% | 102.10 | +0.8% |
| EPS, basic (₹) | 4.29 | 4.59 | −6.5% | 4.26 | +0.7% |
| Net margin (%) | 10.9 | 15.2 | 12.7 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 290.10 | 286.70 | +1.2% | 306.70 | −5.4% |
| Other income | 22.60 | 22.30 | +1.3% | 17.50 | +29.1% |
| Total income | 312.70 | 309.00 | +1.2% | 324.20 | −3.5% |
| Profit before tax | 49.00 | 66.10 | −25.9% | 77.50 | −36.8% |
| Net profit for the period | 34.80 | 49.90 | −30.3% | 59.90 | −41.9% |
| EPS, basic (₹) | 1.45 | 2.09 | −30.6% | 2.50 | −42.0% |
| Net margin (%) | 12.0 | 17.4 | 19.5 |
Consolidated
- Filed with BSE
- 29 Jan 2026, 19:10 IST
- Board meeting
- 29 Jan 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 29 Jan 2026, 19:10 IST
- Board meeting
- 29 Jan 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE